Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Systematic influenza vaccination in the pediatric population.
Otero-Barrós MT, Durán-Parrondo C. Otero-Barrós MT, et al. An Pediatr (Engl Ed). 2023 Jan;98(1):1-2. doi: 10.1016/j.anpede.2022.11.003. Epub 2022 Nov 29. An Pediatr (Engl Ed). 2023. PMID: 36460607 Free article. No abstract available.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Niessen FA, Machado A, Launay O, Denayer S, Seyler L, Baruch J, Burgui C, Loghin II, Domegan L, Vaikutytė R, Husa P, Panagiotakopoulos G, Aouali N, Dürrwald R, Howard J, Pozo F, Sastre-Palou B, Nonković D, Knol MJ, Kislaya I, Luong Nguyen LB, Bossuyt N, Demuyser T, Džiugytė A, Martínez-Baz I, Popescu C, Duffy R, Kuliešė M, Součková L, Michelaki S, Simon M, Reiche J, Otero-Barrós MT, Lovrić Makarić Z, Bruijning-Verhagen PC, Gomez V, Lesieur Z, Barbezange C, Van Nedervelde E, Borg ML, Castilla J, Lazar M, O'Donnell J, Jonikaitė I, Demlová R, Amerali M, Wirtz G, Tolksdorf K, Valenciano M, Bacci S, Kissling E; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to the named authors). Rose AM, et al. Among authors: otero barros mt. Euro Surveill. 2023 Nov;28(47):2300186. doi: 10.2807/1560-7917.ES.2023.28.47.2300186. Euro Surveill. 2023. PMID: 37997666 Free PMC article.
Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain.
Pardo-Seco J, Mallah N, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F. Pardo-Seco J, et al. Among authors: otero barros mt. Int J Environ Res Public Health. 2022 Mar 29;19(7):4039. doi: 10.3390/ijerph19074039. Int J Environ Res Public Health. 2022. PMID: 35409724 Free PMC article.
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022.
Suárez Rodríguez B, Guzmán Herrador BR, Díaz Franco A, Sánchez-Seco Fariñas MP, Del Amo Valero J, Aginagalde Llorente AH, de Agreda JPAP, Malonda RC, Castrillejo D, Chirlaque López MD, Chong Chong EJ, Balbuena SF, García VG, García-Cenoz M, Hernández LG, Montalbán EG, Carril FG, Cortijo TG, Bueno SJ, Sánchez AL, Linares Dópido JA, Lorusso N, Martins MM, Martínez Ochoa EM, Mateo AM, Peña JM, Antón AIN, Otero Barrós MT, Martinez MDCP, Jiménez PP, Martín OP, Rivas Pérez AI, García MS, Response Group NM, Soria FS, Sierra Moros MJ. Suárez Rodríguez B, et al. Among authors: otero barros mt. Emerg Infect Dis. 2022 Sep;28(9):1847-1851. doi: 10.3201/eid2809.221051. Epub 2022 Jul 12. Emerg Infect Dis. 2022. PMID: 35820165 Free PMC article.
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
Fontán-Vela M, Hernando V, Olmedo C, Coma E, Martínez M, Moreno-Perez D, Lorusso N, Vázquez Torres M, Barbas Del Buey JF, Roig-Sena J, Pastor E, Galmés Truyols A, Artigues Serra F, Sancho Martínez RM, Latasa Zamalloa P, Pérez Martínez O, Vázquez Estepa A, García Rojas AJ, Barreno Estévez AI, Sánchez-Migallón Naranjo A, Pérez Martín JJ, Peces Jiménez P, Morales Romero R, Castilla J, García Cenoz M, Huerta Huerta M, Boone ALD, Macías Ortiz MJ, Álvarez Río V, Rodríguez Recio MJ, Merino Díaz M, Berradre Sáenz B, Villegas-Moreno MT, Limia A, Diaz A, Monge S; Spanish MPOX Vaccine Effectiveness Study Group. Fontán-Vela M, et al. Clin Infect Dis. 2024 Feb 17;78(2):476-483. doi: 10.1093/cid/ciad645. Clin Infect Dis. 2024. PMID: 37864849 Free PMC article.
COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain.
Mallah N, Pardo-Seco J, Ares-Gómez S, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro-Sánchez C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F. Mallah N, et al. Among authors: otero barros mt. Pediatr Allergy Immunol. 2023 Oct;34(10):e14037. doi: 10.1111/pai.14037. Pediatr Allergy Immunol. 2023. PMID: 37877845
Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain.
Mallah N, Pardo-Seco J, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F. Mallah N, et al. Among authors: otero barros mt. Environ Res. 2022 Dec;215(Pt 2):114252. doi: 10.1016/j.envres.2022.114252. Epub 2022 Sep 10. Environ Res. 2022. PMID: 36096168 Free PMC article.
[Impact of COVID-19 pandemic in terms of incidence and lethality in nursing homes in Galicia (Spain)].
Losada-Castillo I, Santiago-Pérez MI, Naveira-Barbeito G, Otero-Barros MT, Pérez-Martínez O, Zubizarreta-Alberdi R. Losada-Castillo I, et al. Among authors: otero barros mt. Rev Esp Geriatr Gerontol. 2022 Sep-Oct;57(5):257-263. doi: 10.1016/j.regg.2022.08.003. Epub 2022 Aug 24. Rev Esp Geriatr Gerontol. 2022. PMID: 36089448 Free PMC article. Spanish.
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
Ares-Gómez S, Mallah N, Pardo-Seco J, Malvar-Pintos A, Pérez-Martínez O, Otero-Barrós MT, Súarez-Gaiche N, Santiago-Pérez MI, González-Pérez JM, López-Pérez LR, Rosón B, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F. Ares-Gómez S, et al. Among authors: otero barros mt. Pediatr Allergy Immunol. 2024 May;35(5):e14131. doi: 10.1111/pai.14131. Pediatr Allergy Immunol. 2024. PMID: 38700124
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
Ares-Gómez S, Mallah N, Santiago-Pérez MI, Pardo-Seco J, Pérez-Martínez O, Otero-Barrós MT, Suárez-Gaiche N, Kramer R, Jin J, Platero-Alonso L, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Piñeiro-Sotelo M, Malvar-Pintos A, González-Pérez JM, Rodríguez-Tenreiro-Sánchez C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F; NIRSE-GAL study group. Ares-Gómez S, et al. Among authors: otero barros mt. Lancet Infect Dis. 2024 Apr 30:S1473-3099(24)00215-9. doi: 10.1016/S1473-3099(24)00215-9. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38701823